Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

NBIXNBIX
Showing 8 of 25 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in NEUROCRINE BIOSCIENCES INC

JACOBS LEVY EQUITY MANAGEMENT, INC holds 726,112 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $122.4M as of 2026-Q2. The position was increased (+39.6% shares). NBIX represents 0.4% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$122.4M

Current Shares

726,112

Total Value Change

+$62M

Total Shares Change

+201,944

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
726,112
+39.6%
$122.4M0.4%$168.54
48
2026-Q1
Increased
520,269
+1389.6%
$68.5M0.3%$131.14
57
2025-Q4
Decreased
34,926
-1.7%
$5M0.0%$140.95
0
2025-Q3
Decreased
35,520
-34.2%
$5M0.0%$140.27
0
2025-Q2
Decreased
54,000
-39.3%
$6.8M0.0%$125.42
0
2025-Q1
Increased
88,915
+32.3%
$9.8M0.0%$113.16
35
2024-Q4
Decreased
67,189
-87.2%
$9.2M0.0%$137.06
0
2024-Q3
Decreased
524,168
-27.3%
$60.4M0.2%$115.06
0

Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used